机构风向标 | 赛升药业(300485)2025年二季度已披露持仓机构仅6家

Group 1 - The core viewpoint of the news is that Sai Sheng Pharmaceutical (300485.SZ) has reported an increase in institutional and foreign investment holdings as of August 21, 2025, indicating growing interest from investors [1][2] - As of the report date, a total of 6 institutional investors hold shares in Sai Sheng Pharmaceutical, with a combined holding of 8.8971 million shares, representing 1.85% of the total share capital, which is an increase of 0.86 percentage points from the previous quarter [1] - The public funds disclosed during this period include two new funds: GF Technology Innovation Mixed A and Huatai-PineBridge CSI 2000 ETF, while two funds were no longer disclosed: JY Shun'an Yuanqi Flexible Allocation Mixed and Wan Jia Medical Quantitative Stock Selection Mixed Initiation A [1] Group 2 - In terms of foreign investment, one foreign fund, Morgan Stanley & Co. International PLC, increased its holdings by 0.16% compared to the previous quarter [2] - Two new foreign institutions disclosed during this period are UBS AG and Barclays Bank PLC, while Hong Kong Central Clearing Limited and Goldman Sachs LLC were no longer disclosed [2]